overactive bladder

Latest Headlines

Latest Headlines

Startup gets $38.5M to take on Medtronic with a smaller overactive bladder, sacral neuro implant

Axonics Modulation Technologies has gained $38.5 million in a Series B round to start a study of its overactive bladder implant in Europe and North America early next year.

AltheRx Pharma adds $15M, new CEO and ex-AstraZeneca exec

After gaining its lead asset from GlaxoSmithKline, AltheRx Pharmaceuticals has made a series of leadership changes through a restructuring plan that features a $15 million investment led by Becker Ventures.

Langer startup Taris tracks down $12.5M round for drug-device combo

Taris Biomedical has gone back to the venture well as the biotech startup launches a midstage study of its lead candidate against bladder pain. The Lexington, MA-based company found support for its latest financing from previous backers at Flybridge Capital Partners, Flagship Ventures, Polaris Venture Partners and Third Rock Ventures.

Nanosphere foam delivers drugs to the bladder

Researchers at the Institute of Plastics Processing (IKV) at RWTH Aachen University in Germany are developing a controlled-release foam that can deliver drugs to treat diseases such as overactive bladder.

Astellas scores FDA panel nod for overactive bladder drug

Astellas is one step closer to building its blockbuster business in overactive bladder meds.

FDA green-light's Antares' overactive bladder gel; Watson to sell it

Antares Pharma's ($AIS) new topical gel to treat overactive bladder will hit the U.S. commercial market in the spring. FDA approval for the drug variation was announced Dec. 8. Fellow New Jersey